BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION

hikma canada limited🇨🇦 Health Canada

Approval Id: 0ab67fdead1f2a97
Drug Approval Canada Name: BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION
Product Name: BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION
Status: Marketed
Status Date: 2023-05-31
Original Market Date: 2021-10-29
Din: 02515377
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Ophthalmic
Schedule: Prescription
Ahfs: 52:40.04
Atc Original: S01EA05 BRIMONIDINE
Atc Name: s 01 ea 05
Aig Number: 0131859001
Company Name: hikma canada limited
Company Address: 5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9

BRIMONIDINE TARTRATE

0.2 % / W/V

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

0ab67fdead1f2a97

Type

Standard